DSIJ Mindshare

Five pharma companies to collaborate for clinical trial of Molnupiravir for treating mild COVID-19

Molnupiravir is an oral anti-viral that inhibits the replication of multiple RNA viruses including SARS-CoV-2.

Apurva Joshi 0 823 Article rating: 4.7

Cipla, Dr Reddy’s Laboratories, Emcure Pharmaceuticals, Sun Pharmaceutical Industries and Torrent Pharmaceuticals have announced today that these five companies will collaborate for the clinical trial of the investigational oral anti-viral drug Molnupiravir for the treatment of mild COVID-19 in an outpatient setting in India.

Power Mech Projects makes 52-week high on bagging project from CCL worth Rs 9,294 crore

As per company’s management, the project will add more than Rs 400 crore annually to its top line.

Apurva Joshi 0 757 Article rating: 4.5

Power Mech Projects Limited has made a new 52-week high of Rs 767.30 today after it won a mine development & operation (MOO) project from Central Coalfields Limited (CCL), a subsidiary of Coal India Limited, aggregating to Rs 9,294 crore over the contract period. 

HFCL to set up second model PM-WANI village in Karnataka after Haryana

This PM-WANI network will provide high-speed Wi-Fi internet to over 9,000 residents of the otherwise poorly-connected village located in Brahmavara Taluk, Udupi district.

Apurva Joshi 0 1425 Article rating: 4.2

HFCL Limited in collaboration with Telecom Infra Project (TIP) has announced setting up their second PM-WANI powered connectivity for Baidebattu village in Karnataka. 

RSS
135678910Last
DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR